Literature DB >> 17357278

Antioxidant mechanism of hepatoprotection by ursodeoxycholic acid in experimental alcoholic steatohepatitis.

O Lukivskaya1, L Zavodnik, M Knas, V Buko.   

Abstract

PURPOSE: The aim of this study was to evaluate the role of an antioxidant factor in the hepatoprotective effect of ursodeoxycholic acid (UDCA) in rat alcoholic steatohepatitis.
MATERIAL AND METHODS: The effects of UDCA (40 mg/kg, i.g., 30 days) were studied using rats fed on a high-fat diet (52% calories as fat) and administered with ethanol via intragastric intubation (4 g/kg daily, 30 days).
RESULTS: The livers of ethanol-treated animals were characterized by fatty dystrophy. The relative liver weight and the square of the sudanophylic area as well as the liver triglyceride content and the activity of the serum marker enzymes, aspartate aminotransferase and gamma-glutamyltransferase, were significantly increased. Elevated superoxide dismutase activity as well as increased contents of lipid peroxidation products (hydroxyalkenals, malone dialdehyde, etc.) and lucigenin-enhanced microsomal chemiluminescence were observed in the liver of ethanol-treated rats and the liver reduced glutathione content was decreased. An increase in monoenoic fatty acids, a decrease of the n-6 acid family and an enhancement of microsomal membrane viscosity were found in the liver of these animals. An elevation of the total cytochrome P-450 content and the activity of amidopyrine-N-demethylase were shown in liver microsomes of the ethanol-treated group. The UDCA treatment improved the liver morphology, decreased serum marker enzyme activities, liver triglyceride content and normalized all the indices of oxidative stress. UDCA lowered the viscosity of the microsomal membrane, as assessed by both the fluorescence probe techniques and the saturated/unsaturated fatty acid ratio. The microsomal cytochrome P-450 content and amidopyrine-N-demethylase activity were normalized in UDCA-treated rats.
CONCLUSIONS: We can conclude that the hepatoprotective effect of UDCA stipulated by its antioxidant properties is indeed the factor enabling UDCA to control metabolic processes by changing the properties of liver membranes and membranous proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17357278

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  10 in total

1.  Effect of ursodeoxycholic acid on liver markers: A systematic review and meta-analysis of randomized placebo-controlled clinical trials.

Authors:  Mario Simental-Mendía; Adriana Sánchez-García; Luis E Simental-Mendía
Journal:  Br J Clin Pharmacol       Date:  2020-04-27       Impact factor: 4.335

2.  Evaluation of Pistacia lentiscus fatty oil effects on glycemic index, liver functions and kidney functions of New Zealand rabbits.

Authors:  Zouhir Djerrou; Y Hamdi-Pacha; A M Belkhiri; H Djaalab; F Riachi; M Serakta; A Boukeloua; Z Maameri
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

Review 3.  Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.

Authors:  R-M Liu; K A Gaston Pravia
Journal:  Free Radic Biol Med       Date:  2009-10-02       Impact factor: 7.376

4.  Ursodeoxycholic Acid ameliorates pain severity and cartilage degeneration in monosodium iodoacetate-induced osteoarthritis in rats.

Authors:  Su-Jin Moon; Jeong-Hee Jeong; Joo Yeon Jhun; Eun Ji Yang; Jun-Ki Min; Jong Young Choi; Mi-La Cho
Journal:  Immune Netw       Date:  2014-02-21       Impact factor: 6.303

Review 5.  Naturally Occurring Nrf2 Activators: Potential in Treatment of Liver Injury.

Authors:  Ravirajsinh N Jadeja; Kapil K Upadhyay; Ranjitsinh V Devkar; Sandeep Khurana
Journal:  Oxid Med Cell Longev       Date:  2016-12-22       Impact factor: 6.543

6.  EFFICIENCY OF BORAGE SEEDS OIL AGAINST GAMMA IRRADIATION-INDUCED HEPATOTOXICITY IN MALE RATS: POSSIBLE ANTIOXIDANT ACTIVITY.

Authors:  Hala A H Khattab; Inas Z A Abdallah; Fatimah M Yousef; Etimad A Huwait
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05

7.  Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.

Authors:  Torsten Diesinger; Vyacheslav Buko; Alfred Lautwein; Radovan Dvorsky; Elena Belonovskaya; Oksana Lukivskaya; Elena Naruta; Siarhei Kirko; Viktor Andreev; Dominik Buckert; Sebastian Bergler; Christian Renz; Edith Schneider; Florian Kuchenbauer; Mukesh Kumar; Cagatay Günes; Berthold Büchele; Thomas Simmet; Dieter Müller-Enoch; Thomas Wirth; Thomas Haehner
Journal:  PLoS One       Date:  2020-07-23       Impact factor: 3.240

8.  Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Maria Nadinskaia; Marina Maevskaya; Vladimir Ivashkin; Khava Kodzoeva; Irina Pirogova; Evgeny Chesnokov; Alexander Nersesov; Jamilya Kaibullayeva; Akzhan Konysbekova; Aigul Raissova; Feruza Khamrabaeva; Elena Zueva
Journal:  World J Gastroenterol       Date:  2021-03-14       Impact factor: 5.742

9.  A Comparative Study of the Hepatoprotective Effect of Centella asiatica Extract (CA-HE50) on Lipopolysaccharide/d-galactosamine-Induced Acute Liver Injury in C57BL/6 Mice.

Authors:  Woojae Hong; Jeon Hwang-Bo; Hyelin Jeon; Minsung Ko; Joongyeon Choi; Yong-Joon Jeong; Jae-Hyun Park; Inhye Kim; Tae-Woo Kim; Hyunggun Kim; Se-Chan Kang
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

10.  Chlorogenic Acid Protects against Advanced Alcoholic Steatohepatitis in Rats via Modulation of Redox Homeostasis, Inflammation, and Lipogenesis.

Authors:  Vyacheslav Buko; Ilya Zavodnik; Grażyna Budryn; Małgorzata Zakłos-Szyda; Elena Belonovskaya; Siarhei Kirko; Dorota Żyżelewicz; Agnieszka Zakrzeska; Aliaksei Bakunovich; Viktor Rusin; Valentina Moroz
Journal:  Nutrients       Date:  2021-11-20       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.